Cargando…
The von Willebrand factor stamps plasmatic extracellular vesicles from glioblastoma patients
Glioblastoma is a devastating tumor of the central nervous system characterized by a poor survival and an extremely dark prognosis, making its diagnosis, treatment and monitoring highly challenging. Numerous studies have highlighted extracellular vesicles (EVs) as key players of tumor growth, invasi...
Autores principales: | Sabbagh, Quentin, André-Grégoire, Gwennan, Alves-Nicolau, Carolina, Dupont, Aurélien, Bidère, Nicolas, Jouglar, Emmanuel, Guével, Laëtitia, Frénel, Jean-Sébastien, Gavard, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611030/ https://www.ncbi.nlm.nih.gov/pubmed/34815502 http://dx.doi.org/10.1038/s41598-021-02254-7 |
Ejemplares similares
-
Inhibition of the pseudokinase MLKL alters extracellular vesicle release and reduces tumor growth in glioblastoma
por: André-Grégoire, Gwennan, et al.
Publicado: (2022) -
Plasmatic ADAMTS-13 metalloprotease and von Willebrand
factor in children with cyanotic congenital heart disease
por: Soares, R.P.S., et al.
Publicado: (2013) -
β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability
por: Harford-Wright, Elizabeth, et al.
Publicado: (2016) -
Pharmacological targeting of apelin impairs glioblastoma growth
por: Harford-Wright, Elizabeth, et al.
Publicado: (2017) -
Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)